PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice

Adenovirus Vector-Induced Innate Inflammatory Mediators, MAPK Signaling, As Well As Adaptive Immune Responses Are Dependent upon Both TLR2 and TLR9 In Vivo

(2014) D. M. Appledorn et al.   JOURNAL OF IMMUNOLOGY

Reversal of Metabolic and Neurological Symptoms of Phenylketonuric Mice Treated with a PAH Containing Helper-Dependent Adenoviral Vector

(2012) Monica Cerreto et al.   CURRENT GENE THERAPY

Balloon Catheter Delivery of Helper-dependent Adenoviral Vector Results in Sustained, Therapeutic hFIX Expression in Rhesus Macaques

(2012) Nicola Brunetti-Pierri et al.   MOLECULAR THERAPY

Comparison of Adenoviruses as Oncolytics and Cancer Vaccines in an Immunocompetent B Cell Lymphoma Model

(2011) Eric A. Weaver et al.   HUMAN GENE THERAPY

Immune Recognition of Gene Transfer Vectors: Focus on Adenovirus as a Paradigm

(2011) Yasser Ali Aldhamen et al.   Frontiers in Immunology

ABC transporters, atherosclerosis and inflammation

(2010) Michael L. Fitzgerald et al.   ATHEROSCLEROSIS

Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies

(2010) Sadik H Kassim et al.   Clinical Lipidology

Gene Therapy to Improve High-Density Lipoprotein Metabolism and Function

(2010) Eline Van Craeyveld et al.   CURRENT PHARMACEUTICAL DESIGN

Species Differences in the Pharmacology and Toxicology of PEGylated Helper-Dependent Adenovirus

(2010) Piyanuch Wonganan et al.   MOLECULAR PHARMACEUTICS

Modifications of Adenovirus Hexon Allow for Either Hepatocyte Detargeting or Targeting With Potential Evasion From Kupffer Cells

(2010) Jan-Michael Prill et al.   MOLECULAR THERAPY

A New Adenovirus Based Vaccine Vector Expressing an Eimeria tenella Derived TLR Agonist Improves Cellular Immune Responses to an Antigenic Target

(2010) Daniel M. Appledorn et al.   PLoS One

Identification of a novel human cellular HDL biosynthesis defect

(2009) S. Rashid et al.   EUROPEAN HEART JOURNAL

Short-Term Rescue of Neonatal Lethality in a Mouse Model of Propionic Acidemia by Gene Therapy

(2009) Sean E. Hofherr et al.   HUMAN GENE THERAPY

Transient Pretreatment With Glucocorticoid Ablates Innate Toxicity of Systemically Delivered Adenoviral Vectors Without Reducing Efficacy

(2009) Sergey S Seregin et al.   MOLECULAR THERAPY

Comparison of Replication-Competent, First Generation, and Helper-Dependent Adenoviral Vaccines

(2009) Eric A. Weaver et al.   PLoS One

Apolipoprotein A-I mimetic peptides

(2008) Brian J. Van Lenten et al.   Current Atherosclerosis Reports

Effects of Shielding Adenoviral Vectors with Polyethylene Glycol on Vector-Specific and Vaccine-Mediated Immune Responses

(2008) Eric A. Weaver et al.   HUMAN GENE THERAPY

Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors

(2008) Nicola Brunetti-Pierri et al.   JOURNAL OF GENE MEDICINE

Modification of Adenoviral Vectors With Polyethylene Glycol Modulates In Vivo Tissue Tropism and Gene Expression

(2008) Sean E Hofherr et al.   MOLECULAR THERAPY